* Baseret på resultaterne af sammenlagte data fra TORO 1 og TORO 2 for ITT- population, viral belastning ved uge 48 for patienter som ikke kom til follow- up, afbrød behandlingen eller fik virologisk svigt erstattet med deres sidste observation (LOCF). # Seneste værdi fremført. ** M- H- test:
* Based on results from pooled data of TORO 1 and TORO 2 on ITT population, week 48 viral load for subjects who were lost to follow-up, discontinued therapy, or had virological failure replaced by their last observation (LOCF). # Last value carried forward. ** M-H test: